Infectious Diseases Related Content
76% of COVID-19 patients still have one symptom, after six months
While long COVID is slowly becoming more understood, ordinary COVID-19 patients are experiencing lasting effects - scientists discovered that 76% of people have atleast one recurring symptom, six months after the original illness.
Infection prevention and control (IPC) for COVID-19 focus
Two divisions of Active Care Group – Christchurch Group and Remeo – discuss the importance of infection prevention and control in the healthcare sector in light of COVID-19.
UK brings in Tier 4 restrictions for South East and London
As of midnight tonight (20 December), London and the South East will enter strict Tier 4 restrictions - which includes no household mixing over Christmas, and no commuting to work.
British company launches fast-acting antimicrobial coating that destroys coronavirus
Here, we learn about a British company launching a fast-acting antimicrobial coating that destroys coronavirus.
LumiBio: COVID-19 infection, prevention and control
Kate Edwards, Director of LumiBio, highlights what we need to know about COVID-19 infection, prevention and control (IPC)
A modern approach to hand hygiene training
SureWash, a CPD certified hand hygiene training company has been helping healthcare facilities globally with the fight against COVID-19. Founder and CTO, Dr Gerard Lacey tells us about their technology and what comes next for the company.
Removal of inflammatory ‘evil humors’ – the key to treating COVID-19 complications?
Phillip P. Chan, MD, PhD, Chief Executive Officer of CytoSorbents Corporation (NASDAQ: CTSO), discusses the use of CytoSorb, a broad-spectrum blood purification technology to treat cytokine storm and hyperinflammation in critically ill COVID-19 patients.
FebriDx: Rapid patient triage test and COVID-19
Here, we discover that FebriDx® rapid point of care triage can help prevent the spread of infection and improve patient streaming.
Transmission of Diarrheagenic E. coli by plants
Ann G. Matthysse, Professor of Biology from The University of North Carolina at Chapel Hill, shares her expertise on the transmission of Diarrheagenic E. coli by plants.
Sterilair PRO – Biological air treatment
Used in medical settings for over 20 years, Sterilair is now being used in a wide range of close-contact environments to maintain healthy air quality.
COVID-19 technologies need greater scrutiny before being rolled out
Dr Jeremy Aroles explores the implications of COVID-19 technologies, and proposes three ways to ensure that these powers can't be abused by the Government.
Diabetes patients are three times as likely to have severe COVID
While diabetes has been declared as a signifier for infection complications, researchers now say that data suggests it is three times as likely these individuals have severe COVID or are hospitalised.
Infodemic: The other face of epidemics (COVID-19)
Dr Sylvie Briand, Director, Global Infectious Hazards Preparedness Department at the World Health Organization, explains how COVID-19 is accompanied by fighting an infodemic.
From COVID-19 to the future of public health surveillance
Andrea Ammon, Director at the European Centre for Disease Prevention and Control, takes us on a journey from COVID-19 to the future of public health surveillance.
Exploring UVC technology for infection control
Anti Viral UVC explores how ultraviolet light works and how UVC energy is an effective and environmentally friendly way to eradicate dangerous microorganisms in any environment.
How is climate change increasing HIV risks for women?
When it comes to HIV risks for women, researchers found that natural disasters force vulnerable women to take any chance to secure resources - whether through transactional sex or engagement in early marriage.
COVID-19 testing labs: Size isn’t everything
When it comes to COVID-19 testing labs, size isn’t everything, according to Alan Thornhill, UK Country Manager at Igenomix and Honorary Professor of Reproductive Genetics at the University of Kent, who spoke to Natalie Broome (MSc student, Kent).
The Moderna vaccine has a final efficiency of 94.1%
The clinical trials are over for the Moderna vaccine - the company announced their drug was 94.1% effective and then filed for Emergency Use.
SureWash over the sink: Combining hand hygiene training & monitoring
SureWash, a hand hygiene training company, has developed a new way of combining training and monitoring of hand washing.
US healthcare workers could get Pfizer vaccine in December
Today (20 November) Pfizer and BioNTech are sending their drug for approval to the FDA, meaning that the most vulnerable Americans could get the vaccine in December.